Advicenne Logo

Advicenne

Develops and commercializes therapies for rare renal diseases for patients of all ages.

ALDVI | PA

Overview

Corporate Details

ISIN(s):
FR0013296746 (+1 more)
LEI:
969500YT5VMEYAYODW34
Country:
France
Address:
262 RUE DU FAUBOURG SAINT-HONORE, 75008 PARIS
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Advicenne is a specialty pharmaceutical company dedicated to developing, commercializing, and marketing innovative treatments for rare diseases. The company's primary focus is on improving the lives of patients with rare renal (nephrological) conditions. Leveraging more than a decade of research and development, Advicenne specializes in creating therapies suitable for both children and adults, underscoring its commitment to making groundbreaking treatments accessible to patients of all ages in international markets.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-28 07:30
Regulatory News Service
Inside Information / Other news releases
English 164.8 KB
2025-07-28 07:30
Regulatory News Service
Informations privilégiées / Autres communiqués
French 178.7 KB
2025-07-25 07:30
Earnings Release
Inside Information / Other news releases
English 177.4 KB
2025-07-25 07:30
Earnings Release
Informations privilégiées / Autres communiqués
French 190.6 KB
2025-05-16 08:00
Post-Annual General Meeting Information
Informations privilégiées / Autres communiqués
French 114.8 KB
2025-04-29 18:00
Registration Form
Rapports financiers et d'audit annuels / Modalités de mise à disposition du rap…
French 182.1 KB
2025-04-29 18:00
Registration Form
Annual financial and audit reports / Terms of availability of the annual financ…
English 152.3 KB
2025-03-27 19:12
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
French 324.3 KB
2025-03-27 19:12
Earnings Release
Inside Information / News release on accounts, results
English 336.8 KB
2025-01-23 18:30
Earnings Release
Informations privilégiées / Information sur chiffre d’affaires annuel
French 233.9 KB
2025-01-23 18:30
Earnings Release
Inside Information / Information on annual revenues
English 243.6 KB
2024-12-19 18:00
M&A Activity
Inside Information / Other news releases
English 196.5 KB
2024-12-19 18:00
M&A Activity
Informations privilégiées / Autres communiqués
French 163.2 KB
2024-11-28 18:00
Report Publication Announcement
Informations privilégiées / Autres communiqués
French 192.1 KB
2024-11-28 18:00
Report Publication Announcement
Inside Information / Other news releases
English 190.8 KB

Automate Your Workflow. Get a real-time feed of all Advicenne filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Advicenne via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2023-10-04 N/A Other Other 1,452,282 3,499,999.62 EUR
2023-10-04 N/A Other Buy 41,493 99,998.13 EUR
2023-10-02 N/A Other Other 414,937 999,998.17 EUR
2023-09-21 N/A Other Sell 22,336 22.34 EUR
2023-09-15 N/A Other Sell 134,492 13.45 EUR

Peer Companies

Company Country Ticker View
Genome&Company Logo
Clinical-stage biopharma developing cancer therapies using microbiome, immune inhibitors, and ADCs.
South Korea 314130
Develops molecular diagnostics using DNA methylation biomarkers for early cancer detection.
South Korea 228760
Genomtec S.A. Logo
Develops a mobile platform for rapid, precise genetic diagnostics at the point-of-care.
Poland GMT
GENOTECH CORP. Logo
A biotech firm offering gene synthesis, genome analysis, and biopharmaceutical products globally.
South Korea 066830
Gentian Diagnostics ASA Logo
Develops & manufactures IVD immunoassays for human & veterinary disease diagnostics.
Norway GENT
GI Innovation Inc. Logo
Develops fusion protein biologics for oncology, allergic, and metabolic diseases.
South Korea 358570
GlaxoSmithKline PLC Logo
A biopharmaceutical company developing vaccines and specialty medicines to prevent and treat disease.
United Kingdom GSK
GL Pharm Tech Corp. Logo
Develops improved drugs and generics, and licenses proprietary drug formulation technologies.
South Korea 204840
GNI  Group Ltd. Logo
Biopharma firm developing novel drugs for cancer and inflammatory diseases using genetics.
Japan 2160
Goodwill Pharma Plc Logo
Integrated pharma CDMO developing Rx/OTC meds, supplements & devices for CEE markets.
Hungary GWPH

Talk to a Data Expert

Have a question? We'll get back to you promptly.